SEC 13F Intelligence

MAAT PHARMA SACA

CUSIP 00BNRR5C1

Maat Pharma Saca has 1 institutional holders in Filings Flow’s 13F database, together reporting 1.4K shares worth $9,752 as of Q2 2024.

Institutional Holders
1
Q2 2024
Reported Value
$9,752
Ticker
unmapped
private placement or foreign
Quarters Tracked
1

Ownership Trend

Institutional holders
Q2 ’24: 1Q2 ’24filingsflow.com
Total reported value
Q2 ’24: $9,752Q2 ’24filingsflow.com

Holders

··
Manager% of PortfolioValueSharesQuarter
Propel Bio Management, LLC$159M AUM0.01%$9,7521.4KQ2 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.